These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 33975462)

  • 21. Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic.
    Richard Q; Alizon S; Choisy M; Sofonea MT; Djidjou-Demasse R
    PLoS Comput Biol; 2021 Mar; 17(3):e1008776. PubMed ID: 33661890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
    Flaxman S; Mishra S; Gandy A; Unwin HJT; Mellan TA; Coupland H; Whittaker C; Zhu H; Berah T; Eaton JW; Monod M; ; Ghani AC; Donnelly CA; Riley S; Vollmer MAC; Ferguson NM; Okell LC; Bhatt S
    Nature; 2020 Aug; 584(7820):257-261. PubMed ID: 32512579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variant-specific interventions to slow down replacement and prevent outbreaks.
    Majeed B; Tosato M; Wu J
    Math Biosci; 2022 Jan; 343():108703. PubMed ID: 34547362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis on dynamical mechanism of multi outbreaks of COVID-19].
    Xiao YN; Li Q; Zhou WK; Peng ZH; Tang SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jun; 42(6):966-976. PubMed ID: 34814495
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of tiered measures on social contact and mixing patterns of in Italy during the second wave of COVID-19.
    Tizzani M; De Gaetano A; Jarvis CI; Gimma A; Wong K; Edmunds WJ; Beutels P; Hens N; Coletti P; Paolotti D
    BMC Public Health; 2023 May; 23(1):906. PubMed ID: 37202734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piecewise-constant optimal control strategies for controlling the outbreak of COVID-19 in the Irish population.
    Náraigh LÓ; Byrne Á
    Math Biosci; 2020 Dec; 330():108496. PubMed ID: 33075364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitigating bias in estimating epidemic severity due to heterogeneity of epidemic onset and data aggregation.
    Krishnan RG; Cenci S; Bourouiba L
    Ann Epidemiol; 2022 Jan; 65():1-14. PubMed ID: 34419601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological characteristics and dynamic transmissions of COVID-19 pandemics in Chinese mainland: A trajectory clustering perspective analysis.
    Chen J; Chen S; Duan G; Zhang T; Zhao H; Wu Z; Yang H; Ding S
    Epidemics; 2023 Dec; 45():100719. PubMed ID: 37783112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China.
    Costantino V; Heslop DJ; MacIntyre CR
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32453411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social Distancing and Transmission-reducing Practices during the 2019 Coronavirus Disease and 2015 Middle East Respiratory Syndrome Coronavirus Outbreaks in Korea.
    Jang WM; Jang DH; Lee JY
    J Korean Med Sci; 2020 Jun; 35(23):e220. PubMed ID: 32537955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions.
    Ragonnet-Cronin M; Boyd O; Geidelberg L; Jorgensen D; Nascimento FF; Siveroni I; Johnson RA; Baguelin M; Cucunubá ZM; Jauneikaite E; Mishra S; Watson OJ; Ferguson N; Cori A; Donnelly CA; Volz E
    Nat Commun; 2021 Apr; 12(1):2188. PubMed ID: 33846321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to COVID-19 in South Korea and implications for lifting stringent interventions.
    Dighe A; Cattarino L; Cuomo-Dannenburg G; Skarp J; Imai N; Bhatia S; Gaythorpe KAM; Ainslie KEC; Baguelin M; Bhatt S; Boonyasiri A; Brazeau NF; Cooper LV; Coupland H; Cucunuba Z; Dorigatti I; Eales OD; van Elsland SL; FitzJohn RG; Green WD; Haw DJ; Hinsley W; Knock E; Laydon DJ; Mellan T; Mishra S; Nedjati-Gilani G; Nouvellet P; Pons-Salort M; Thompson HA; Unwin HJT; Verity R; Vollmer MAC; Walters CE; Watson OJ; Whittaker C; Whittles LK; Ghani AC; Donnelly CA; Ferguson NM; Riley S
    BMC Med; 2020 Oct; 18(1):321. PubMed ID: 33032601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the effects of public health measures against COVID-19.
    Yin ZJ; Xiao H; McDonald S; Brusic V; Qiu TY
    J Med Virol; 2023 Dec; 95(12):e29301. PubMed ID: 38087460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting COVID-19 spread in the face of control measures in West Africa.
    Taboe HB; Salako KV; Tison JM; Ngonghala CN; Glèlè Kakaï R
    Math Biosci; 2020 Oct; 328():108431. PubMed ID: 32738248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Jail Decarceration and Anticontagion Policies With COVID-19 Case Growth Rates in US Counties.
    Reinhart E; Chen DL
    JAMA Netw Open; 2021 Sep; 4(9):e2123405. PubMed ID: 34473257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Kohanovski I; Obolski U; Ram Y
    Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.
    Lemaitre JC; Perez-Saez J; Azman AS; Rinaldo A; Fellay J
    Swiss Med Wkly; 2020 May; 150():w20295. PubMed ID: 32472939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the comprehensive non-pharmaceutical interventions and measures in containing the COVID-19 epidemic in Shenzhen: a retrospective study.
    Xu S; Liu P; Mei S; Lv Q; Cheng C; Lu Y; Kong D; Wu X; Wen Y; Cao B; Gao S; Xiong H; Zhao J; Huang Y; Luo Y; Feng T
    BMJ Open; 2021 Jul; 11(7):e044940. PubMed ID: 34312193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.